GLOBAL MICROBIAL API MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Name: Global Microbial API Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy
Keywords: Global Microbial API Market, Global Microbial API Market Report, Global Microbial API Industry Report, Global Microbial API Market Size, Global Microbial API Market Share, Global Microbial API Market Analysis, Global Microbial API Market Growth, Global Microbial API Market Trends, Global Microbial API Market Overview, Global Microbial API Market Forecast

Global Microbial API Market, By Host (Mammalian, Bacterial, Fungal), By Type (Antibody, Peptide, Protein, Small Molecule, Vaccine, By Site, In-house, Outsourced), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In : Dec 2023
Code : CMI6508
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Recent Developments:

On August 24, 2023, Antheia, Inc., a pharmaceutical ingredient manufacturing company, announced the successful completion of its first 116,000 L manufacturing unit in the U.S. with a commercially relevant fermentation for the manufacturing of active pharmaceutical ingredients (APIs) for producing critical medicines for Antheia's pipeline.
On November 27, 2023, Rusan Pharma Ltd., an India-based pharmaceutical company, announced that it had launched a new microbial and conventional active pharmaceutical ingredient (API) manufacturing facility in Madhya Pradesh, India. The company has invested around US$ 36.1 million in its manufacturing unit.

GLOBAL MICROBIAL API MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Market News

Global Microbial API Market Report Snapshots

EXISTING CLIENTELE